Study challenges current treatment for mild asthma
People with "mild persistent asthma" -- about a quarter of all asthma sufferers -- appear to gain adequate relief by inhaling anti-inflammatory steroids only during periods of bad symptoms, rather than daily as current guidelines recommend, a new study shows
